Immuno AG

Last updated

Immuno AG was a major [1] pharmaceutical company founded in 1960 by Dr. Otto Schwarz & Dr. Hans Eibl [2] with headquarters in Vienna, Austria. [3]

Contents

In 1996 the company was acquired by Baxter for $715 million. [4]

Business

Immuno manufactured blood products including factor VIII and factor IX [5] such as Kryobulin and Krobulin TIM. [6]

Lawsuits

In 1983 Immuno sued Dr. Shirley McGreal and several others claiming $4 million in damages for an article claiming the company planned to use captured chimpanzees for hepatitis research in Sierra Leone. [7] [8]

In 1986 two civil lawsuits were brought against Immuno by the Association Against Animal Experimentation in regard to treatment of chimpanzees. [9]

The plant in Krems, which was set up in 2002 but never went into operation, was subjected to an examination of its further usability in the course of 2013. The partial expansion was announced in autumn 2013: "In the first expansion stage, a production line is initially planned, and there is sufficient space for possible future expansions. The investment volume is estimated at 138 million euros. The start of construction is planned for the first quarter of 2014." [10]

Related Research Articles

<span class="mw-page-title-main">Siemens</span> German multinational conglomerate company

Siemens AG is a German multinational technology conglomerate. It is focused on industrial automation, distributed energy resources, rail transport and health technology. Siemens is the largest industrial manufacturing company in Europe, and holds the position of global market leader in industrial automation and industrial software.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">ThyssenKrupp</span> German multinational conglomerate steel corporation

ThyssenKrupp AG is a German industrial engineering and steel production multinational conglomerate. It resulted from the 1999 merger of Thyssen AG and Krupp and has its operational headquarters in Duisburg and Essen. The company claims to be one of the world's largest steel producers, and it was ranked tenth-largest worldwide by revenue in 2015. It is divided into 670 subsidiaries worldwide. The largest shareholders are the Alfried Krupp von Bohlen und Halbach Foundation and Cevian Capital. ThyssenKrupp's products range from machines and industrial services to high-speed trains, elevators, and shipbuilding. The subsidiary ThyssenKrupp Marine Systems also manufactures frigates, corvettes, and submarines for the German and foreign navies.

<span class="mw-page-title-main">CSL Limited</span> Australian biotechnology company

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.

<span class="mw-page-title-main">Miles Laboratories</span> American pharmacetical and health care company

Miles Laboratories was founded as the Dr. Miles Medical Company in Elkhart, Indiana, in 1884 by Dr. Franklin L. Miles, a specialist in the treatment of eye and ear disorders, with an interest in the connection of the nervous system to overall health. The company is known for inventing products such as Alka-Selzer and One-A-Day vitamins.

<span class="mw-page-title-main">Armour and Company</span> Former American company

Armour & Company was an American company and was one of the five leading firms in the meat packing industry. It was founded in Chicago, in 1863, by the Armour brothers led by Philip Danforth Armour. By 1880, the company had become Chicago's most important business and had helped make Chicago and its Union Stock Yards the center of America's meatpacking industry. During the same period, its facility in Omaha, Nebraska, boomed, making the city's meatpacking industry the largest in the nation by 1959. In connection with its meatpacking operations, the company also ventured into pharmaceuticals and soap manufacturing, introducing Dial soap in 1948.

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

Jan Moor-Jankowski was a Polish-born American primatologist and a fighter for Polish independence against Nazi Germany. Dr. Moor-Jankowski was Director of the Laboratory for Experimental Medicine and Surgery in Primates (LEMSIP) which he founded in 1965, the Director of the World Health Organization Collaborating Center for Hematology of Primate Apes, and the editor-in-chief of the Journal of Medical Primatology.

Voestalpine AG – stylized as voestalpine – is an Austrian steel-based technology and capital goods group based in Linz, Austria. The company is active in steel, automotive, railway systems, profilform and tool steel industries. As of 2017, it is one of the few profitable steel companies in Europe.

ams OSRAM AG, formerly known as Austria Microsystems AG and ams AG, is an Austrian electronics company that designs and manufactures sensors for small form factor, low power, highest sensitivity and multi-sensor applications. Products include sensors, sensor ICs, interfaces and related software for mobile, consumer, communications, industrial, medical, and automotive markets.

<span class="mw-page-title-main">Celgene</span> American biopharmaceutical company

Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.

<span class="mw-page-title-main">Regeneron Pharmaceuticals</span> American biotechnology company

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Contaminated hemophilia blood products were a serious public health problem in the late 1970s up to 1985.

Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories.

<span class="mw-page-title-main">Lidl</span> German multinational discount supermarket chain owned by the Schwarz Group

Lidl is a German international discount retailer chain that operates over 12,000 stores, present in every member state of the European Union, Serbia, Switzerland, the United Kingdom and the United States. Headquartered in Neckarsulm, Baden-Württemberg, the company belongs to the Schwarz Group, which also includes hypermarket chain Kaufland.

<span class="mw-page-title-main">ARAG SE</span> European insurance group

ARAG SE is a European insurance group. ARAG stands for Allgemeine Rechtsschutzversicherungs Aktiengesellschaft. "SE" stands for "Societas Europaea". Its headquarters are located in the ARAG-Tower in Düsseldorf. The ARAG Group employs almost 4,700 people worldwide. The Group reported total gross premium income of €2.02 billion in 2021. ARAG is the largest family-owned German insurance group, with a legal insurance portfolio of 4.7 million policies in the 2021 business year. The Group's international legal insurance business accounts for 2.9 million policies alone, making it the largest legal insurer in the world. The Group's total insurance business was 12.2 million policies in 2021, 8.4 million of which were outside Germany.

<span class="mw-page-title-main">Bayer</span> German multinational pharmaceutical and biotechnology company

Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.

<span class="mw-page-title-main">Contaminated blood scandal in the United Kingdom</span> The historical contamination of blood products in the UK with HIV and hepatitis C virus

The contaminated blood scandal, also known as the infected blood scandal, is a British medical scandal in which a large number of people were infected with hepatitis C and HIV, as a result of receiving contaminated blood or contaminated clotting factor products. Many of the products were imported from the US, and distributed to patients by the National Health Service throughout the 1970s and 1980s. Most recipients had haemophilia or had received a blood transfusion following childbirth or surgery. It has been estimated that more than 30,000 patients received contaminated blood, resulting in the deaths of at least 3,000 people. In July 2017, Prime Minister Theresa May announced an independent public inquiry into the scandal, for which she was widely praised as successive governments going back to the 1980s had refused such an inquiry. May stated that "the victims and their families who have suffered so much pain and hardship deserve answers as to how this could possibly have happened." The final report was published in seven volumes on 20 May 2024, concluding that the scandal could have been largely avoided, patients were knowingly exposed to "unacceptable risks", and that doctors, the government and NHS tried to cover-up what happened by "hiding the truth".

References

  1. Whiteside, R. M.; Wilson, A.; Blackburn, S.; Hörnig, S. E.; Wilson, C. P. (6 December 2012). Major Companies of Europe 1990/91 Volume 3: Major Companies of Western Europe Outside the European Economic Community. Springer Science & Business Media. ISBN   9789400908017 via Google Books.
  2. Stern, Joe. "In Memoriam of Dr. Otto Schwarz - Plasma Protein Therapeutics Association (PPTA)".
  3. "Immuno AG".
  4. Thomas M. Burton (30 August 1996). "Baxter Confirms Pact To Acquire Immuno". Wall Street Journal.
  5. "Method of producing a factor-VIII(AHF)-high-concentrate".
  6. "Final Report: Chapter 23 - Viral Inactivation of Blood Products for Haemophilia Therapy up to 1985".
  7. "Abroad at Home; Abusing The Law". The New York Times. 10 May 1991.
  8. "IMMUNO, A.G., APPELLANT, v. JAN MOOR-JANKOWSKI, RESPONDENT".
  9. Information, Reed Business (21 August 1986). "New Scientist". Reed Business Information via Google Books.{{cite web}}: |first= has generic name (help)
  10. "Baxter Österreich - News & Medien - Pressemitteilungen - 2013 - Gesundheitsunternehmen Baxter investiert in Pharmaproduktion in Krems". 2014-05-06. Archived from the original on 2014-05-06. Retrieved 2022-08-19.